The acute effect of a single-dose of caffeine on the P300 event-related brain potential (ERP) was assessed in a study using a repeatedly presented auditory oddball button-press task. A dose (5mg/kg body-weight) of either caffeine or placebo lactose, dissolved in a cup of decaffeinated coffee, was administered double-blindly to coffee drinkers who had abstained from coffee for 24hrs, with the presentation order of the sessions counterbalanced and separated by 2-4 weeks. The caffeine-treatment condition demonstrated a smaller P300 amplitude and a shorter latency overall than the placebo treatment condition. The mean P300 amplitude value difference (caffeine minus placebo) increased with the successive trial blocks. Caffeine ingestion appears to yield a lower resource-consumption and a net increase in allocating attention resources for task performance across repeated measurements.
Introduction
Caffeine is the most widely consumed psycho-stimulating constituent worldwide through coffee, tea, soft drinks, confectioneries, and medications such as tonic drugs and overthe-counter remedies for colds and flu. A cup of coffee usually contains some 100-150 mg of caffeine, and tea contains slightly less '-". People in many countries habitually drink tea and/or coffee every day to get refreshed and to maintain a sense of wellbeing. The daily caffeine intake of adults in Western societies is averaged to be 200-300 mg3). An estimation shows that more than 85% of Americans consume caffeine, yielding a daily per capita consumption of 1-2 cups, and the annual total caffeine consumption in the U.S. alone is 15 billion grams ,.47. To these people, caffeine provides an indispensable, positive, and reinforcing stimulus in their daily lives, as it is long and widely-alleged to be able to elevate mood, reduce fatigue, and improve physical and mental efficiency, possibly by increasing alertness, attention, energy, and motivation for work"57~. For some individuals, however, caffeine may introduce clinically significant detrimental effects such as discomfort or anxiety, etc.; and dependent or withdrawal symptoms such as headaches, sleepiness, fatigue, and depression, etc. ""'. It is obvious that caffeine plays an important role in the daily life-events of human society, and exerts a farreaching impact on the public health and well-being of the majority of the world's population. Empirical observation has also demonstrated a possibility for caffeine to play a more active rule in the so-called 24-hour society in the future, because it offers a "natural" and widely available manipulation of human arousal, vigilance and the sleep-alarm cycle. Therefore, better knowledge of the psychophysiological actions of caffeine will enable us to find solid strategies to utilize caffeine to promote public health and elevate work efficiency, as well as to tackle its detrimental effects more effectively.
Since the last century, the overwhelming popularity of daily caffeine consumption has attracted investigations into its effects on human performance and mood 9.~2~. Despite extensive studies, however, the psychophysiological actions of caffeine have not yet been well-established 9,3,4~. Recent evidence suggests that caffeine improves vigilance and performance of cognitive tasks ,5.,(,), and enhances sustained auditory attention and selective visual attention 12,13,17). It improves the selection of relevant and irrelevant information by facilitating more rapid mental processing and more efficient allocation of attention to relevant stimuli ~3.,~ Evidence also suggests that caffeine exerts its cognitive and behavioral actions by interacting with a multitude of variables, such as intake levels, type of environment (novel vs. boring), and dosages, etc. '"~. This predisposes a major difficulty in caffeine research, since so many variables, both known and unknown, will potentially affect the results. Nevertheless, the prevalence of daily caffeine consumption throughout the world and its beneficial actions, as well as the clinical importance of its unwelcome mental effects on the general public, make it essential to further characterize its psychophysiological effects.
The amplitude of P300 event-related brain potential (ERP) demonstrates a systematic decline across repeated measurement 2''2'. This important characteristic suggests that the P300 reflect Caffeine on Repeatedly Measured P300 fundamental neurophysiological activities related to changes in the mnestic representation of the stimulus environment resembling the orienting response 2~ It also has been linked to changes in the amount of attention resources allocated as required time-on-task increases 24.25~. Moreover, repeated measurement will provide more "close-to-nature" testing conditions for the caffeine's psychophysiological effects, because in the real world, the majorities of human life-events (writing, speaking, reading, and walking, etc.) occur in repeated fashion.
The present study assessed how caffeine affects P300 measurements with repeatedly presented stimuli in order to look for new insights on the psychophysiological mechanism that may underlie the beneficial as well as detrimental effects of caffeine.
Materials and methods
Nine healthy male (M=30.7, SD= + 3.8 years) regular coffee consumers (1-2 cup/day), with normal sleep patterns, free from prescribed medication and naive to electrophysiological studies, signed a consent form and volunteered their time or were paid for their participation. The subjects were administered either caffeine or a placebo once in two sessions separated by 2-4 weeks under double-blind and counterbalanced presentation conditions ~.~.~s). They abstained from caffeine-containing substances, alcohol and smoking for 24hrs before each test, had lunch before 12:00 noon and were assessed between 5:00 to 6:30 p.m. Each subject received 5mg/kg (275-375 mg) caffeine or lactose dissolved in a cup of normally brewed decaffeinated coffee. About 30 min after consumption, when caffeine reached its peak plasma level 20, the ERP recording began.
A simple and widely used auditory oddball button-press task has been employed to elicit the P300. The stimuli were sinusoidal tones (70 dB SPL, 10 ms rise/fall, 50 ms plateau), presented binaurally through earphones, at 3 sec inter-stimulus-intervals (ISI). The target stimulus was always a 2000 Hz tone randomly occurring with a probability of 0.2; the standard stimulus was always a 1000 Hz tone with a probability of 0.8. They were delivered continuously until approximately 20 artifact-free target trials were averaged, which defined one trial block. A total of 6 blocks was obtained from each subject, since this procedure would produce robust P300 habituation 2~). The inter-block interval was about 40 sec, during which the subjects rested and the recorded data was stored.
The subjects were seated in a comfortable chair, and instructed to fixate on a point 0.8 m directly ahead and avoid eye-blinks or eye-movement to prevent artifact-rejection. They were also instructed to respond only to the target stimulus by pressing a button as quickly as possible, with the response time,
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artifact-rejection and error rate being recorded. Electroencephalographic (EEG) activity was recorded using Ag/AgCl plated electrodes at Fz, Cz and Pz of the 10-20 systems, referred to linked earlobes with a forehead ground. Two additional electrodes were placed at the outer canthus and supraorbitally to the left eye with a bipolar recording made of electro-ocular (EOG) activity. Electric impedance of all electrode sites was kept below 5 K~. EEG was recorded using a 0.02-30 Hz bandpass and digitized at 0.8 ms per point for 800 ms with a I00 ms prestimulus baseline. Waveforms were averaged online, with EEG or EOG trials exceeding + 100laV rejected automatically. Table 1 is a summary of the behavioral performance from each drug-treatment and trial block. A two-factor analysis of variance (ANOVA) (2 drug-treatment • 6 trial blocks) of the response time, rejection and error rate showed neither a significant drug treatment effect nor an interaction of this variable with the trial block (P>O.05 in all cases). Thus the drug treatment did not affect performance across the trial blocks, most likely because of the very simple nature of the target detection response task. s~o T1ME (me) TIME (m~ Fig. 1 Representative avenged P300 for target stimulus from each drag treatment condition and trial blocks at each electrode site.
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